🔎 Trials Near Me

መነሻ › የኮሎሬክታል ካንሰር › ኮነቲከት › New Haven

በNew Haven፣ CT ለየኮሎሬክታል ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየኮሎሬክታል ካንሰር የሚደረጉ 20 ጥናቶች በNew Haven እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Yale University School of Medicine /ID# 279373, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07525206

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale Cancer Center, New Haven
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Exelixis Clinical Site #62, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT05176483

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale University School of Medicine, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06324357

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Yale Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07578571

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Yale New Haven Hospital /ID# 270565, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT06820463

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Yale University School Of Medicine, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06662786

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale-New Haven Hospital-Yale Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06445062

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Yale Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ሴፕቴ 2026 · NCT07349537

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale University School of Medicine - Yale Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT05786924

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Yale Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT04929223

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Clinical Study Site, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07228832

A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Yale University, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06992258

FOG-001 in Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale University School of Medicine, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05919264

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale University, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ጁላይ 2026 · NCT05691491

A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale Comprehensive Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁላይ 2026 · NCT07169734

A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale University, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ጁላይ 2026 · NCT07079631

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Smilow Cancer Hospital (Yale University), New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Yale University, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT06917079

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Yale University, Yale Cancer Center, New Haven
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ማርች 2026 · NCT06395519

በሌሎች ከተሞች ለየኮሎሬክታል ካንሰር የሚደረጉ ጥናቶች

በNew Haven ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።